Germany Post-Traumatic Stress Disorder (PTSD) Market is expected to grow with a CAGR of 4.4% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.
The Germany post-traumatic stress disorder (PTSD) market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.
Some of the major players dealing in the Germany Post-Traumatic Stress Disorder (PTSD) Market are introducing a wide range of products along with adopting strategic initiatives such as acquisitions, agreements, business expansions, and awards and recognitions into the market. These help companies maximize sales with an enhanced product portfolio.
AbbVie Inc. is the dominating player in the Germany Post-Traumatic Stress Disorder (PTSD) Market. The other key players existing in the market are Viatris Inc, Pfizer Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Aurobindo Pharma., AstraZeneca, Cipla Inc., Lupin, Accord Healthcare GmbH, Dr. Reddy’s Laboratories Ltd., Zydus Pharmaceuticals, Inc., GlaxoSmithKline Group of Companies., Teva Pharmaceutical Industries Ltd., Alkermes. and Novartis AG. among others.
AbbVie Inc. was founded in the year 2013 and is headquartered in Illnois, U.S. The company is a biopharmaceutical company engaged in new approaches to addressing today’s health issues, from life-threatening illnesses to chronic conditions. It has several product categories, including Immunology, Oncology, Aesthetics, Neuroscience, Eye care products, Women’s health products, Virology, Other Specialty Areas, and Gastroenterology, of which Neuroscience is the market-focused category.
It has a wide presence across North America, the Middle East and Africa, South America, Europe and Asia-Pacific. It has various subsidiaries that include Allergan, AbbVie GK, AbbVie Ireland unlimited company, Allergan Finance, Zeltiq Anesthetics, Stemcentrx, and AbbVie SAS, among others.
Viatris Inc. was founded in the year 2020 and is headquartered in Canonsburg, Pennsylvania, United States. The company is engaged in producing and manufacturing a wide range of therapeutic products and the quality of medication. It has product categories Therapeutic Areas, Brands, generics, Biosimilars, Over counter, and API, in which Brands is the market-focused category.
The company has a wide presence across North America, Europe, South America, Asia-Pacific, and Middle East, and Africa.
Pfizer Inc. was founded in the year 1848 and is headquartered in New York, U.S. The company focuses on delivering breakthroughs that change patients' lives and translates advanced science and technologies into therapies. It has several product categories, including Primary care, Specialty care, and Oncology, in which Specialty care is the market-focused category.
The company has a presence across North America, Europe, Asia Pacific, South America, and Middle East & Africa.
Germany Post-Traumatic Stress Disorder (PTSD) Market – Industry Trends and Forecast to 2030